Literature DB >> 11523989

Identification of amino acids in the tetratricopeptide repeat and C-terminal domains of protein phosphatase 5 involved in autoinhibition and lipid activation.

H Kang1, S L Sayner, K L Gross, L C Russell, M Chinkers.   

Abstract

Protein phosphatase 5 (PP5) exhibits low basal activity due to the autoinhibitory properties of its N-terminal and C-terminal domains but can be activated approximately 40-fold in vitro by polyunsaturated fatty acids. To identify residues involved in regulating PP5 activity, we performed scanning mutagenesis of its N-terminal tetratricopeptide repeat (TPR) domain and deletion mutagenesis of its C-terminal domain. Mutating residues in a groove of the TPR domain that binds to heat shock protein 90 had no effect on basal phosphatase activity. Mutation of Glu-76, however, whose side chain projects away from this groove, resulted in a 10-fold elevation of basal activity without affecting arachidonic acid-stimulated activity. Thus, the interface of the TPR domain involved in PP5 autoinhibition appears to be different from that involved in heat shock protein 90 binding. We also observed a 10-fold elevation of basal phosphatase activity upon removing the C-terminal 13 amino acids of PP5, with a concomitant 50% decrease in arachidonic acid-stimulated activity. These two effects were accounted for by two distinct amino acid deletions: deleting the four C-terminal residues (496-499) of PP5 had no effect on its activity, but removing Gln-495 elevated basal activity 10-fold. Removal of a further three amino acids had no additional effect, but deleting Asn-491 resulted in a 50% reduction in arachidonic acid-stimulated activity. Thus, Glu-76 in the TPR domain and Gln-495 at the C-terminus were implicated in maintaining the low basal activity of PP5. While the TPR domain alone has been thought to mediate fatty acid activation of PP5, our data suggest that Asn-491, near its C-terminus, may also be involved in this process.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11523989     DOI: 10.1021/bi010999i

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  34 in total

1.  Cytokines alter glucocorticoid receptor phosphorylation in airway cells: role of phosphatases.

Authors:  Belaid Bouazza; Kateryna Krytska; Manel Debba-Pavard; Yassine Amrani; Richard E Honkanen; Jennifer Tran; Omar Tliba
Journal:  Am J Respir Cell Mol Biol       Date:  2012-05-16       Impact factor: 6.914

2.  The conserved N-terminal region of the mitotic checkpoint protein BUBR1: a putative TPR motif of high surface activity.

Authors:  V M Bolanos-Garcia; S Beaufils; A Renault; J G Grossmann; S Brewerton; M Lee; A Venkitaraman; T L Blundell
Journal:  Biophys J       Date:  2005-07-22       Impact factor: 4.033

3.  The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active-Site Catalytic Metals in PPP5C.

Authors:  Brandon M D'Arcy; Mark R Swingle; Cinta M Papke; Kevin A Abney; Erin S Bouska; Aishwarya Prakash; Richard E Honkanen
Journal:  Mol Cancer Ther       Date:  2019-01-24       Impact factor: 6.261

4.  Protein phosphatase 5 and the tumor suppressor p53 down-regulate each other's activities in mice.

Authors:  Jun Wang; Tao Shen; Wuqiang Zhu; Longyu Dou; Hao Gu; Lingling Zhang; Zhenyun Yang; Hanying Chen; Qi Zhou; Edwin R Sánchez; Loren J Field; Lindsey D Mayo; Zhongwen Xie; Deyong Xiao; Xia Lin; Weinian Shou; Weidong Yong
Journal:  J Biol Chem       Date:  2018-09-27       Impact factor: 5.157

5.  The subcellular localization of plant protein phosphatase 5 isoforms is determined by alternative splicing.

Authors:  Sergio de la Fuente van Bentem; Jack H Vossen; Josephus E M Vermeer; Marianne J de Vroomen; Theodorus W J Gadella; Michel A Haring; Ben J C Cornelissen
Journal:  Plant Physiol       Date:  2003-09-04       Impact factor: 8.340

6.  Molecular basis for TPR domain-mediated regulation of protein phosphatase 5.

Authors:  Jing Yang; S Mark Roe; Matthew J Cliff; Mark A Williams; John E Ladbury; Patricia T W Cohen; David Barford
Journal:  EMBO J       Date:  2004-12-02       Impact factor: 11.598

7.  A gain-of-function mutation in the second tetratricopeptide repeat of TFIIIC131 relieves autoinhibition of Brf1 binding.

Authors:  Robyn D Moir; Karen V Puglia; Ian M Willis
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

8.  Human protein phosphatase 5 dissociates from heat-shock proteins and is proteolytically activated in response to arachidonic acid and the microtubule-depolymerizing drug nocodazole.

Authors:  Tamás Zeke; Nick Morrice; Cristina Vázquez-Martin; Patricia T W Cohen
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

9.  FKBP51 controls cellular adipogenesis through p38 kinase-mediated phosphorylation of GRα and PPARγ.

Authors:  Lance A Stechschulte; Terry D Hinds; Saja S Khuder; Weinian Shou; Sonia M Najjar; Edwin R Sanchez
Journal:  Mol Endocrinol       Date:  2014-06-16

Review 10.  Protein phosphatase 5.

Authors:  Terry D Hinds; Edwin R Sánchez
Journal:  Int J Biochem Cell Biol       Date:  2007-08-30       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.